autoimmune disease therapy (Asahi/Vernalis)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameautoimmune disease therapy (Asahi/Vernalis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVernalis PlcAsahi Kasei Pharma Corp
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A